These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31931086)
1. Histologic comparison of tumor necrosis factor-α inhibitor-induced psoriasis and psoriasis vulgaris. Hu JZ; Billings SD; Yan D; Fernandez AP J Am Acad Dermatol; 2020 Jul; 83(1):71-77. PubMed ID: 31931086 [TBL] [Abstract][Full Text] [Related]
2. Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-α inhibitor-induced psoriasis: A case-control study. Ya J; Hu JZ; Nowacki AS; Khanna U; Mazloom S; Kabbur G; Husni ME; Fernandez AP J Am Acad Dermatol; 2020 Dec; 83(6):1599-1605. PubMed ID: 32592879 [TBL] [Abstract][Full Text] [Related]
3. TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic. Mazloom SE; Yan D; Hu JZ; Ya J; Husni ME; Warren CB; Fernandez AP J Am Acad Dermatol; 2020 Dec; 83(6):1590-1598. PubMed ID: 30576759 [TBL] [Abstract][Full Text] [Related]
4. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies. Laga AC; Vleugels RA; Qureshi AA; Velazquez EF Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526 [TBL] [Abstract][Full Text] [Related]
9. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical Psoriasis in Children Receiving Anti-TNFα Treatment for Inflammatory/autoimmune Disease. Rosenwasser N; Lee D; Sidbury R; Zhao Y Paediatr Drugs; 2021 Mar; 23(2):131-141. PubMed ID: 33761130 [TBL] [Abstract][Full Text] [Related]
11. Histopathologic features of inverse psoriasis. Knabel M; Mudaliar K J Cutan Pathol; 2022 Mar; 49(3):246-251. PubMed ID: 34611907 [TBL] [Abstract][Full Text] [Related]
12. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha? Cuchacovich R; Espinoza CG; Virk Z; Espinoza LR J Clin Rheumatol; 2008 Dec; 14(6):353-6. PubMed ID: 19033869 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis. Cohen JN; Bowman S; Laszik ZG; North JP J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047 [TBL] [Abstract][Full Text] [Related]
15. Eosinophils Among the Histological Features of Psoriasis. Penn L; Brinster NK Am J Dermatopathol; 2019 May; 41(5):347-349. PubMed ID: 30422830 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate. Wu JJ; Guérin A; Sundaram M; Dea K; Cloutier M; Mulani P J Am Acad Dermatol; 2017 Jan; 76(1):81-90. PubMed ID: 27894789 [TBL] [Abstract][Full Text] [Related]